Long
BOTHE end of the falling wedge
Hello All,
Fact News:
Phase 2B:
globenewswire.com/news-release/2021/01/12/2156714/0/en/Bone-Therapeutics-treats-first-patient-in-ALLOB-Phase-IIb-tibial-fracture-study.html
New partnership:
globenewswire.com/news-release/2021/01/14/2158343/0/en/Bone-Therapeutics-and-Rigenerand-sign-partnership-for-cell-therapy-process-development.html
Nice falling wedge on a weekly chart for Bone Therapeutics, and looks ready to breakout.
Also, the MA20 is ready to break up the MA50.
The falling wedge gives us a target @ 11,30€ around 290% from today's buying.
But for that, the chart needs to break 2 historic supports around 4.5€ and around 6.8€
Let's see if they are enough volume to strongly break this falling wedge!
Mathieu
Fact News:
Phase 2B:
globenewswire.com/news-release/2021/01/12/2156714/0/en/Bone-Therapeutics-treats-first-patient-in-ALLOB-Phase-IIb-tibial-fracture-study.html
New partnership:
globenewswire.com/news-release/2021/01/14/2158343/0/en/Bone-Therapeutics-and-Rigenerand-sign-partnership-for-cell-therapy-process-development.html
Nice falling wedge on a weekly chart for Bone Therapeutics, and looks ready to breakout.
Also, the MA20 is ready to break up the MA50.
The falling wedge gives us a target @ 11,30€ around 290% from today's buying.
But for that, the chart needs to break 2 historic supports around 4.5€ and around 6.8€
Let's see if they are enough volume to strongly break this falling wedge!
Mathieu
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.